Spyre Therapeutics, Inc. (SYRE)
73.22
+0.22
(+0.30%)
USD |
NASDAQ |
May 07, 16:00
73.59
+0.37
(+0.51%)
After-Hours: 05:04
Spyre Therapeutics Research and Development Expense (Annual) : 171.65M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tyra Biosciences, Inc. | 102.38M |
| Replimune Group, Inc. | 191.22M |
| Savara, Inc. | 81.40M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Agios Pharmaceuticals, Inc. | 334.36M |